Analyst Price Targets — MDT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 21, 2026 9:35 am | — | Goldman Sachs | $84.00 | $78.15 | TheFly | Medtronic reinstated with a Neutral at Goldman Sachs |
| April 23, 2026 7:40 pm | Matthew Taylor | Jefferies | $95.00 | $83.79 | TheFly | Medtronic price target lowered to $95 from $108 at Jefferies |
| April 15, 2026 12:39 pm | Richard Newitter | Truist Financial | $95.00 | $86.88 | TheFly | Medtronic price target lowered to $95 from $103 at Truist |
| April 13, 2026 2:43 pm | — | Mizuho Securities | $120.00 | $86.75 | TheFly | Medtronic price target lowered to $120 from $125 at Mizuho |
| April 9, 2026 12:33 pm | Vijay Kumar | Evercore ISI | $106.00 | $87.91 | TheFly | Medtronic price target lowered to $106 from $108 at Evercore ISI |
| March 10, 2026 2:30 pm | Mike Kratky | Leerink Partners | $119.00 | $90.31 | StreetInsider | Leerink Partners Reiterates Outperform Rating on Medtronic, Inc. (MDT): acquisition an "incremental positive" |
| March 10, 2026 1:43 pm | Michael Matson | Needham | $120.00 | $90.21 | StreetInsider | Needham Reiterates Buy Rating on Medtronic, Inc. (MDT): "glad to see MDT increasingly pursue tuck-in acquisitions" |
| February 18, 2026 12:50 pm | — | Robert W. Baird | $100.00 | $96.41 | TheFly | Medtronic price target lowered to $100 from $103 at Baird |
| February 18, 2026 10:12 am | Matt Miksic | Barclays | $118.00 | $96.41 | TheFly | Medtronic price target raised to $118 from $116 at Barclays |
| February 9, 2026 11:14 am | — | Needham | $121.00 | $102.90 | TheFly | Medtronic upgraded to Buy from Hold at Needham |
Latest News for MDT
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
High energy prices have investors worried about a recession; these businesses should survive the hit just fine.
Medtronic shares have declined ~25% since February amid sector headwinds and a disappointing MiniMed spin-off. Recent bolt-on acquisitions—SPR Therapeutics, CathWorks, and Scientia Vascular—signal Medtronic's focus on innovation and future growth. At $75, Medtronic trades at 13–14x adjusted FY2026 earnings guidance, with a dividend yield near 4%.
Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.